LT Pharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LT Pharma
Largest movements
- Receivables within one year +€99,262
up €99,262 (+50.2%), from €197,879 to €297,141
of which Trade receivables: +€88,700
- Cash -€20,344
down €20,344 (-3.6%), from €561,322 to €540,978
mainly Receivables within one year (-€99,262) and Debts after one year (-€59,907)
- Profit (loss) carried forward +€122,899
up €122,899 (+12.6%), from €973,832 to €1.1m
- Debts after one year -€59,907
down €59,907 (-10.7%), from €559,131 to €499,224
- Gross operating margin -€2,716
down €2,716 (-1.5%), from €182,138 to €179,422
- Depreciation +€1,898
up €1,898 (+28.0%), from €6,767 to €8,665
From the 2022 result to the 2023 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2022 and 2023 balance sheets and the 2023 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2022 | 2023 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,620,882 | €1,683,474 | +€62,592 | +3.9% |
| Fixed assets | 21/28 | €812,586 | €805,153 | -€7,433 | -0.9% |
| Tangible fixed assets | 22/27 | €12,538 | €5,105 | -€7,433 | -59.3% |
| Furniture and vehicles | 24 | €12,538 | €5,105 | -€7,433 | -59.3% |
| Financial fixed assets | 28 | €800,048 | €800,048 | = | 0.0% |
| Current assets | 29/58 | €808,296 | €878,321 | +€70,025 | +8.7% |
| Amounts receivable within one year | 40/41 | €197,879 | €297,141 | +€99,262 | +50.2% |
| Trade receivables | 40 | €174,800 | €263,500 | +€88,700 | +50.7% |
| Other amounts receivable | 41 | €23,079 | €33,641 | +€10,562 | +45.8% |
| Cash at bank and in hand | 54/58 | €561,322 | €540,978 | -€20,344 | -3.6% |
| Deferred charges and accrued income | 490/1 | €49,095 | €40,202 | -€8,893 | -18.1% |
| Total equity and liabilities | 10/49 | €1,620,882 | €1,683,474 | +€62,592 | +3.9% |
| Equity | 10/15 | €994,292 | €1,117,191 | +€122,899 | +12.4% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €973,832 | €1,096,731 | +€122,899 | +12.6% |
| Amounts payable | 17/49 | €626,590 | €566,283 | -€60,307 | -9.6% |
| Amounts payable after more than one year | 17 | €559,131 | €499,224 | -€59,907 | -10.7% |
| Financial debts | 170/4 | €559,131 | €499,224 | -€59,907 | -10.7% |
| Amounts payable within one year | 42/48 | €67,459 | €67,059 | -€400 | -0.6% |
| Current portion of amounts payable after more than one year | 42 | €59,907 | €60,584 | +€677 | +1.1% |
| Trade debts | 44 | €2,083 | €2,794 | +€711 | +34.1% |
| Suppliers | 440/4 | €2,083 | €2,794 | +€711 | +34.1% |
| Taxes, remuneration and social security | 45 | €648 | €1,424 | +€776 | +119.8% |
| Taxes | 450/3 | €648 | €1,424 | +€776 | +119.8% |
| Other amounts payable | 47/48 | €4,821 | €2,257 | -€2,564 | -53.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €6,767 | €8,665 | +€1,898 | +28.0% |
| Other operating charges | 640/8 | €1,233 | €1,824 | +€591 | +47.9% |
| Gross operating margin | 9900 | €182,138 | €179,422 | -€2,716 | -1.5% |
| Operating profit (loss) | 9901 | €174,138 | €168,933 | -€5,205 | -3.0% |
| Financial charges | 65/66B | €9,550 | €9,413 | -€137 | -1.4% |
| Recurring financial charges | 65 | €9,550 | €9,413 | -€137 | -1.4% |
| Profit (loss) for the period before taxes | 9903 | €164,588 | €159,520 | -€5,068 | -3.1% |
| Income taxes | 67/77 | €37,736 | €36,621 | -€1,115 | -3.0% |
| Profit (loss) for the period | 9904 | €126,852 | €122,899 | -€3,953 | -3.1% |
| Profit (loss) for the period to be appropriated | 9905 | €126,852 | €122,899 | -€3,953 | -3.1% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2022 and 31 December 2023. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.